Mayne Pharma Group Limited
MAYNF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$93,836 | -$174,233 | -$317,351 | -$209,481 |
| Dep. & Amort. | $72,777 | $71,621 | $75,782 | $82,381 |
| Deferred Tax | $0 | $0 | $49,994 | $63,419 |
| Stock-Based Comp. | $3,956 | $0 | $6,776 | $4,577 |
| Change in WC | $42,657 | $25,170 | $145,420 | -$8,875 |
| Other Non-Cash | -$8,085 | $62,142 | -$3,333 | $60,773 |
| Operating Cash Flow | $17,469 | -$15,300 | -$43,123 | -$16,618 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$12,276 | -$7,950 | -$219,585 | -$11,853 |
| Net Acquisitions | $0 | $6,854 | $842,217 | $5,167 |
| Inv. Purchases | $0 | $0 | -$127,526 | $0 |
| Inv. Sales/Matur. | $0 | $89,268 | $0 | $0 |
| Other Inv. Act. | -$55,797 | -$34,723 | -$21,621 | -$21,840 |
| Investing Cash Flow | -$68,073 | $53,449 | $473,485 | -$28,526 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3,846 | -$10,948 | -$371,645 | $39,787 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$148 | -$10,932 | -$6,223 | $0 |
| Dividends Paid | $0 | $0 | -$45,292 | $0 |
| Other Fin. Act. | $3,438 | $2,030 | -$8,315 | -$12,186 |
| Financing Cash Flow | -$556 | -$19,850 | -$431,475 | $27,601 |
| Forex Effect | $931 | -$847 | -$2,943 | $6,823 |
| Net Chg. in Cash | -$50,229 | $17,452 | -$4,056 | -$1,308 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $110,068 | $92,616 | $97,080 | $97,980 |
| End Cash | $59,839 | $110,068 | $101,714 | $96,672 |
| Free Cash Flow | $5,193 | -$36,162 | -$262,708 | -$28,471 |